WILMINGTON, Del., October 6, 2026 – Delrin, a leading innovator in high-performance acetal homopolymer solutions, today announced the launch of Delrin 4D™, a groundbreaking mono-material drug delivery demonstration device with all plastic parts developed entirely from Delrin®. The innovation showcases how a simplified, high-performance design approach can help enable the future of more sustainable, efficient, and functional medical devices.
As healthcare manufacturers face increasing pressure to improve performance, reduce complexity, enhance sustainability, and support circular economy objectives, Delrin 4DTM demonstrates a new way of thinking about device design. By utilizing Delrin® throughout the device, the demonstrator highlights the potential benefits of a mono-material approach while maintaining the demanding performance characteristics required for advanced drug delivery systems.
“Delrin 4DTM is more than a demonstration device. It represents a new approach to medical device design that challenges conventional thinking about materials, functionality, and sustainability,” said Eric De Coster, Chief Commercial Officer at Delrin. “By showcasing what can be achieved with a single high-performance polymer, we seek to inspire device developers to explore innovative ways to simplify designs, improve manufacturing efficiency, and support circularity objectives without compromising performance.”
Delrin 4DTM demonstrates several key advantages that a mono-material design strategy can help provide, including:
- Design simplification and functional integration
- Reduced material complexity
- Replacement of metal components
- Enhanced manufacturing efficiency
- Reduced product carbon footprint potential
- Improved recyclability and circularity opportunities
The demonstrator was specifically developed to show how the industry can address challenges associated with traditional multi-material injection device designs, which can complicate manufacturing, sourcing, recycling, and end-of-life management. Delrin 4DTM highlights how the mechanical strength, stiffness, dimensional stability, fatigue resistance, and processing advantages of Delrin® can help support a simplified device architecture capable of delivering advanced functionality.
Delrin 4DTM has already generated significant interest from pharmaceutical companies, device OEMs, and contract development organizations as Delrin continues collaborating with industry leaders to explore future opportunities in medical device innovation.
“The future of drug delivery starts by asking different questions,” added De Coster “Delrin 4DTM demonstrates what’s possible when material science, engineering innovation, and sustainability objectives come together to rethink the design process from the ground up.”
Delrin 4DTM will be showcased at leading medical and pharmaceutical industry events and serves as a platform for collaboration with medical device manufacturers seeking to develop the next generation of high-performance, more sustainable drug delivery solutions.
About Delrin®
Delrin® is the leading global producer of acetal homopolymer (POM), delivering exceptional performance, consistency, and reliability for applications requiring strength, stiffness, durability, low friction, and dimensional stability. Delrin serves customers worldwide across healthcare, automotive, industrial, consumer, mobility, and specialty applications, helping engineers solve complex design challenges while advancing sustainability objectives.
Delrin Media Contact
John Lenox
Global Communications Lead, Delrin
[email protected]